Mutations in Sarcomeric Genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in Patients With Hypertrophic Cardiomyopathy

被引:58
作者
Garcia-Castro, Monica [1 ]
Coto, Eliecer [1 ]
Reguero, Julian R. [2 ]
Berrazueta, Jose R. [3 ]
Alvarez, Victoria [1 ]
Alonso, Belen [1 ]
Sainz, Rocio [3 ]
Martin, Maria [2 ]
Moris, Cesar [2 ]
机构
[1] Hosp Univ Cent Asturias, Inst Invest Nefrol, Oviedo, Asturias, Spain
[2] Univ Oviedo, Hosp Cent Asturias, Serv Cardiol, E-33080 Oviedo, Asturias, Spain
[3] Hosp Marques Valdecilla, Serv Cardiol, Santander, Cantabria, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2009年 / 62卷 / 01期
关键词
Hypertrophic cardiomyopathy; Sudden cardiac death; Mutations; Sarcomeric genes; MYOSIN HEAVY-CHAIN; BINDING PROTEIN-C; CARDIAC TROPONIN-T; LEFT-VENTRICULAR HYPERTROPHY; ALPHA-TROPOMYOSIN GENE; MALIGNANT MUTATIONS; MISSENSE MUTATION; PREVALENCE; SPECTRUM; DISEASE;
D O I
10.1016/S0300-8932(09)70020-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives. Mutation of a sarcomeric gene is the most frequent cause of hypertrophic cardiomyopathy. For each such gene, however, previous studies have reported a range of different mutation frequencies, and clinical manifestations have been highly heterogeneous, both of which limit the use of genetic information in clinical practice. Our aim was to determine the frequency of mutations in the sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in a cohort of Spanish patients with hypertrophic cardiomyopathy. Methods. We used sequencing to analyze the coding regions of these five genes in 120 patients (29% with a family history) and investigated how the patient phenotype varied with the gene mutated. Results. In total, 32 patients were found to have mutations: 10 in MYH7 (8%), 20 in MYBPC3 (16%), 2 in TNNT2, 1 in TPM1 and none in TNNI3. Overall, 61% of mutations had not been described before. Two patients had two mutations (i.e., double mutants). There was no difference in the mean age at diagnosis or the extent of the hypertrophy between those with MYH7 mutations and those with MYBPC3 mutations. Conclusions. Some 26% of patients had a mutation in one of the five sarcomeric genes investigated. More than half of the mutations had not been described before. The MYBPC3 gene was the most frequently mutated, followed by MYH7. No phenotypic differences were observed between carriers of the various mutations, which makes it difficult to use genetic information to stratify risk in these patients.
引用
收藏
页码:48 / 56
页数:9
相关论文
共 33 条
[1]   Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy - A comprehensive outpatient perspective [J].
Ackerman, MJ ;
VanDriest, SL ;
Ommen, SR ;
Will, ML ;
Nishimura, RA ;
Tajik, AJ ;
Gersh, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (12) :2042-2048
[2]   Phenotypic diversity in hypertrophic cardiomyopathy [J].
Arad, M ;
Seidman, JG ;
Seidman, CE .
HUMAN MOLECULAR GENETICS, 2002, 11 (20) :2499-2506
[3]   Clinical features of hypertrophic cardiomyopathy caused by mutation of a ''hot spot'' in the alpha-tropomyosin gene [J].
Coviello, DA ;
Maron, BJ ;
Spirito, P ;
Watkins, H ;
Vosberg, HP ;
Thierfelder, L ;
Schoen, FJ ;
Seidman, JG ;
Seidman, CE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (03) :635-640
[4]   Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy [J].
Erdmann, J ;
Daehmlow, S ;
Wischke, S ;
Senyuva, M ;
Werner, U ;
Raible, J ;
Tanis, N ;
Dyachenko, S ;
Hummel, M ;
Hetzer, R ;
Regitz-, V .
CLINICAL GENETICS, 2003, 64 (04) :339-349
[5]  
García-Castro I, 2003, REV ESP CARDIOL, V56, P1022
[6]   Hypertrophic cardiomyopathy linked to homozygosity for a new mutation in the myosin-binding protein C gene (A627V) suggests a dosage effect [J].
García-Castro, M ;
Reguero, JR ;
Alvarez, V ;
Batalla, A ;
Soto, MI ;
Albaladejo, V ;
Coto, E .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 102 (03) :501-507
[7]   Hypertrophic cardiomyopathy:: Low frequency of mutations in the β-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients [J].
García-Castro, M ;
Reguero, JR ;
Batalla, A ;
Díaz-Molina, B ;
González, P ;
Alvarez, V ;
Cortina, A ;
Cubero, GI ;
Coto, E .
CLINICAL CHEMISTRY, 2003, 49 (08) :1279-1285
[8]   Prevalence and spectrum of mutations in the sarcomeric troponin T and I genes in a cohort of Spanish cardiac hypertrophy patients [J].
Garcia-Castro, Monica ;
Reguero, Julian R. ;
Moris, Cesar ;
Alonso-Montes, Cristina ;
Berrazueta, Jose R. ;
Sainz, Rocio ;
Alvarez, Victoria ;
Coto, Eliecer .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 121 (01) :115-116
[9]   High-risk hypertrophic cardiomyopathy associated with a novel mutation in cardiac myosin-binding protein C [J].
Garcia-Pavia, Pablo ;
Segovia, Javier ;
Molano, Jesus ;
Mora, Roberto ;
Kontny, Frederic ;
Berge, Knut Erik ;
Leren, Trond P. ;
Alonso-Pulpon, Luis .
REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (03) :311-314
[10]   A MOLECULAR-BASIS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE MISSENSE MUTATION [J].
GEISTERFERLOWRANCE, AAT ;
KASS, S ;
TANIGAWA, G ;
VOSBERG, HP ;
MCKENNA, W ;
SEIDMAN, CE ;
SEIDMAN, JG .
CELL, 1990, 62 (05) :999-1006